(Q47261967)

12 January 2018

title

Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer (English)

1 reference

12 January 2018

author name string

Witton CJ

1

1 reference

12 January 2018

Hawe SJ

2

1 reference

12 January 2018

Cooke TG

3

1 reference

12 January 2018

Bartlett JM

4

1 reference

12 January 2018

publication date

1 July 2004

1 reference

12 January 2018

published in

Histopathology

1 reference

12 January 2018

volume

45

1 reference

12 January 2018

issue

1

1 reference

12 January 2018

page(s)

47-54

1 reference

12 January 2018

The role of cyclooxygenases in inflammation, cancer, and development

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

The clinical evaluation of HER-2 status: which test to use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Regulation of cyclooxygenase-2 pathway by HER2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

Aromatase and COX-2 expression in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01898.X

10.1111/J.1365-2559.2004.01898.X

21 January 2018

Identifiers

DOI

1 reference

12 January 2018

1 reference

12 January 2018